Mumps risk factors

	Mumps Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Mumps from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Mumps risk factors On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mumps risk factors All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mumps risk factors
CDC on Mumps risk factors
Mumps risk factors in the news
Blogs on Mumps risk factors
Directions to Hospitals Treating Mumps
Risk calculators and risk factors for Mumps risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]; Nate Michalak, B.A.

Overview

Acceptable presumptive evidence of immunity to mumps includes: documented administration of two doses of live mumps virus vaccine at least 28 days apart, on or after the first birthday; laboratory evidence of immunity; birth before 1957; or documentation of physician-diagnosed mumps.
Individuals with only 1 dose of the MMR or MMRV vaccine are at higher risk than those with 2 doses.

The risk of exposure to mumps among travelers can be high in most countries of the world, especially for travelers who are older than 12 months and who do not have evidence of mumps immunity.

Working or living in close proximity to an individual infected with Rubulavirus (e.g. classrooms, college dormatories).